299 related articles for article (PubMed ID: 25405729)
21. Investigation on quantitative structure activity relationships and pharmacophore modeling of a series of mGluR2 antagonists.
Zhang MQ; Zhang XL; Li Y; Fan WJ; Wang YH; Hao M; Zhang SW; Ai CZ
Int J Mol Sci; 2011; 12(9):5999-6023. PubMed ID: 22016641
[TBL] [Abstract][Full Text] [Related]
22. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA.
Pirhadi S; Ghasemi JB
Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.
Leonetti F; Favia A; Rao A; Aliano R; Paluszcak A; Hartmann RW; Carotti A
J Med Chem; 2004 Dec; 47(27):6792-803. PubMed ID: 15615528
[TBL] [Abstract][Full Text] [Related]
24. Discovery of FIXa inhibitors by combination of pharmacophore modeling, molecular docking, and 3D-QSAR modeling.
Li P; Peng J; Zhou Y; Li Y; Liu X; Wang L; Zuo Z
J Recept Signal Transduct Res; 2018 Jun; 38(3):213-224. PubMed ID: 29724133
[TBL] [Abstract][Full Text] [Related]
25. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
26. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
Khan N; Halim SA; Khan W; Zafar SK; Ul-Haq Z
J Mol Graph Model; 2019 Jun; 89():199-214. PubMed ID: 30908997
[TBL] [Abstract][Full Text] [Related]
27. 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds.
Caballero J
J Mol Graph Model; 2010 Nov; 29(3):363-71. PubMed ID: 20863730
[TBL] [Abstract][Full Text] [Related]
28. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
Ul-Haq Z; Khan N; Zafar SK; Moin ST
Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
[TBL] [Abstract][Full Text] [Related]
29. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.
Wu HQ; Yao J; He QQ; Chen FE
SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254
[TBL] [Abstract][Full Text] [Related]
30. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
Pasha FA; Muddassar M; Neaz MM; Cho SJ
J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057
[TBL] [Abstract][Full Text] [Related]
31. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
Halim SA; Zaheer-ul-Haq
Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
[TBL] [Abstract][Full Text] [Related]
32. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
Sethi KK; Verma SM
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
[TBL] [Abstract][Full Text] [Related]
33. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
[TBL] [Abstract][Full Text] [Related]
34. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
35. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
Mondal C; Halder AK; Adhikari N; Jha T
Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
[TBL] [Abstract][Full Text] [Related]
37. 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.
Dessalew N; Singh SK
Med Chem; 2008 Jul; 4(4):313-21. PubMed ID: 18673142
[TBL] [Abstract][Full Text] [Related]
38. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico.
Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW
J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286
[TBL] [Abstract][Full Text] [Related]
39. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
40. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
Jiang YR; Yang YY; Chen YL; Liang ZJ
Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
